MKKGY
Price
$25.77
Change
+$0.42 (+1.66%)
Updated
Sep 5 closing price
Capitalization
55.52B
68 days until earnings call
SUPN
Price
$46.00
Change
+$0.57 (+1.25%)
Updated
Sep 5 closing price
Capitalization
2.58B
65 days until earnings call
Interact to see
Advertisement

MKKGY vs SUPN

Header iconMKKGY vs SUPN Comparison
Open Charts MKKGY vs SUPNBanner chart's image
Merck KGaA
Price$25.77
Change+$0.42 (+1.66%)
Volume$72.39K
Capitalization55.52B
Supernus Pharmaceuticals
Price$46.00
Change+$0.57 (+1.25%)
Volume$657.58K
Capitalization2.58B
MKKGY vs SUPN Comparison Chart in %
Loading...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MKKGY vs. SUPN commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKKGY is a Hold and SUPN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (MKKGY: $25.77 vs. SUPN: $46.00)
Brand notoriety: MKKGY and SUPN are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: MKKGY: 51% vs. SUPN: 77%
Market capitalization -- MKKGY: $55.52B vs. SUPN: $2.58B
MKKGY [@Pharmaceuticals: Generic] is valued at $55.52B. SUPN’s [@Pharmaceuticals: Generic] market capitalization is $2.58B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MKKGY’s FA Score shows that 1 FA rating(s) are green whileSUPN’s FA Score has 0 green FA rating(s).

  • MKKGY’s FA Score: 1 green, 4 red.
  • SUPN’s FA Score: 0 green, 5 red.
According to our system of comparison, SUPN is a better buy in the long-term than MKKGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MKKGY’s TA Score shows that 2 TA indicator(s) are bullish while SUPN’s TA Score has 3 bullish TA indicator(s).

  • MKKGY’s TA Score: 2 bullish, 5 bearish.
  • SUPN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, SUPN is a better buy in the short-term than MKKGY.

Price Growth

MKKGY (@Pharmaceuticals: Generic) experienced а +1.38% price change this week, while SUPN (@Pharmaceuticals: Generic) price change was +1.95% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

MKKGY is expected to report earnings on Nov 13, 2025.

SUPN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKKGY($55.5B) has a higher market cap than SUPN($2.58B). SUPN has higher P/E ratio than MKKGY: SUPN (40.00) vs MKKGY (16.77). SUPN YTD gains are higher at: 27.212 vs. MKKGY (-8.380). MKKGY has higher annual earnings (EBITDA): 5.87B vs. SUPN (174M). MKKGY has more cash in the bank: 1.57B vs. SUPN (523M). SUPN has less debt than MKKGY: SUPN (31.8M) vs MKKGY (9.4B). MKKGY has higher revenues than SUPN: MKKGY (21.2B) vs SUPN (665M).
MKKGYSUPNMKKGY / SUPN
Capitalization55.5B2.58B2,152%
EBITDA5.87B174M3,374%
Gain YTD-8.38027.212-31%
P/E Ratio16.7740.0042%
Revenue21.2B665M3,188%
Total Cash1.57B523M301%
Total Debt9.4B31.8M29,566%
FUNDAMENTALS RATINGS
MKKGY vs SUPN: Fundamental Ratings
MKKGY
SUPN
OUTLOOK RATING
1..100
618
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
9539
SMR RATING
1..100
7080
PRICE GROWTH RATING
1..100
6339
P/E GROWTH RATING
1..100
91100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKKGY's Valuation (22) in the null industry is somewhat better than the same rating for SUPN (78) in the Pharmaceuticals Other industry. This means that MKKGY’s stock grew somewhat faster than SUPN’s over the last 12 months.

SUPN's Profit vs Risk Rating (39) in the Pharmaceuticals Other industry is somewhat better than the same rating for MKKGY (95) in the null industry. This means that SUPN’s stock grew somewhat faster than MKKGY’s over the last 12 months.

MKKGY's SMR Rating (70) in the null industry is in the same range as SUPN (80) in the Pharmaceuticals Other industry. This means that MKKGY’s stock grew similarly to SUPN’s over the last 12 months.

SUPN's Price Growth Rating (39) in the Pharmaceuticals Other industry is in the same range as MKKGY (63) in the null industry. This means that SUPN’s stock grew similarly to MKKGY’s over the last 12 months.

MKKGY's P/E Growth Rating (91) in the null industry is in the same range as SUPN (100) in the Pharmaceuticals Other industry. This means that MKKGY’s stock grew similarly to SUPN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MKKGYSUPN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
54%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 18 days ago
60%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 12 days ago
58%
Bearish Trend 5 days ago
64%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIBRX31.370.12
+0.38%
Thornburg Investment Income Builder R3
HRLZX9.570.03
+0.31%
Hartford Real Asset R6
TEFRX8.860.02
+0.23%
Templeton Foreign R
DISIX24.92N/A
N/A
BNY Mellon Small Cap Stock Index I
AFOIX19.69N/A
N/A
Alger Mid Cap Focus I

MKKGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKKGY
1D Price
Change %
MKKGY100%
+1.66%
MKGAF - MKKGY
49%
Loosely correlated
+1.49%
AMPH - MKKGY
25%
Poorly correlated
+0.79%
ZTS - MKKGY
25%
Poorly correlated
+0.08%
SUPN - MKKGY
25%
Poorly correlated
+1.25%
INDV - MKKGY
24%
Poorly correlated
+1.01%
More

SUPN and

Correlation & Price change

A.I.dvisor tells us that SUPN and DVAX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SUPN and DVAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
+1.25%
DVAX - SUPN
29%
Poorly correlated
+0.80%
SNDL - SUPN
27%
Poorly correlated
+1.64%
ACET - SUPN
27%
Poorly correlated
+1.00%
ESPR - SUPN
26%
Poorly correlated
+5.93%
HROW - SUPN
26%
Poorly correlated
+2.18%
More